{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T18:45:14Z","timestamp":1771008314150,"version":"3.50.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,3,2]],"date-time":"2022-03-02T00:00:00Z","timestamp":1646179200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,3,2]],"date-time":"2022-03-02T00:00:00Z","timestamp":1646179200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1007\/s11010-022-04395-3","type":"journal-article","created":{"date-parts":[[2022,3,2]],"date-time":"2022-03-02T16:02:56Z","timestamp":1646236976000},"page":"1669-1679","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["CircWHSC1 expedites cervical cancer progression via miR-532-3p\/LTBP2 axis"],"prefix":"10.1007","volume":"477","author":[{"given":"Yan","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fandong","family":"Meng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chengguang","family":"Sui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2403-0322","authenticated-orcid":false,"given":"Dali","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,3,2]]},"reference":[{"key":"4395_CR1","doi-asserted-by":"publisher","first-page":"e191","DOI":"10.1016\/S2214-109X(19)30482-6","volume":"8","author":"M Arbyn","year":"2020","unstructured":"Arbyn M, Weiderpass E, Bruni L, de Sanjose S, Saraiya M, Ferlay J, Bray F (2020) Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis. Lancet Glob Health 8:e191\u2013e203. https:\/\/doi.org\/10.1016\/S2214-109X(19)30482-6","journal-title":"Lancet Glob Health"},{"key":"4395_CR2","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/S0140-6736(18)32470-X","volume":"393","author":"PA Cohen","year":"2019","unstructured":"Cohen PA, Jhingran A, Oaknin A, Denny L (2019) Cervical cancer. Lancet 393:169\u2013182. https:\/\/doi.org\/10.1016\/S0140-6736(18)32470-X","journal-title":"Lancet"},{"key":"4395_CR3","doi-asserted-by":"publisher","unstructured":"Phillips P, Phillips J (2017) Hysterectomy with radiotherapy or chemotherapy or both for women with locally advanced cervical cancer. Clin Nurse Spec 31:189\u2013190. https:\/\/doi.org\/10.1097\/NUR.0000000000000304","DOI":"10.1097\/NUR.0000000000000304"},{"key":"4395_CR4","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/nrc3958","volume":"15","author":"HE Barker","year":"2015","unstructured":"Barker HE, Paget JT, Khan AA, Harrington KJ (2015) The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence. Nat Rev Cancer 15:409\u2013425","journal-title":"Nat Rev Cancer"},{"key":"4395_CR5","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.1097\/CM9.0000000000000465","volume":"132","author":"D Li","year":"2019","unstructured":"Li D, Yang Y, Li ZQ, Li LC, Zhu XH (2019) Circular RNAs: from biogenesis and function to diseases. Chin Med J (Engl) 132:2457\u20132464. https:\/\/doi.org\/10.1097\/CM9.0000000000000465","journal-title":"Chin Med J (Engl)"},{"key":"4395_CR6","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1002\/jcp.29009","volume":"235","author":"S Chaichian","year":"2020","unstructured":"Chaichian S, Shafabakhsh R, Mirhashemi SM, Moazzami B, Asemi Z (2020) Circular RNAs: a novel biomarker for cervical cancer. J Cell Physiol 235:718\u2013724. https:\/\/doi.org\/10.1002\/jcp.29009","journal-title":"J Cell Physiol"},{"key":"4395_CR7","doi-asserted-by":"publisher","DOI":"10.1089\/cbr.2020.3865","author":"L Lin","year":"2020","unstructured":"Lin L, Li N, Hu X, Sun J, He Y (2020) Identification of circ_0085616 as an upregulated and oncogenic circular RNA in cervical cancer via the miR-503-5p-mediated ATXN7L3 activation. Cancer Biother Radiopharm. https:\/\/doi.org\/10.1089\/cbr.2020.3865","journal-title":"Cancer Biother Radiopharm"},{"key":"4395_CR8","doi-asserted-by":"publisher","first-page":"4807","DOI":"10.2147\/CMAR.S242615","volume":"12","author":"J Jiao","year":"2020","unstructured":"Jiao J, Jiao X, Liu Q, Qu W, Ma D, Zhang Y, Cui B (2020) The Regulatory role of circRNA_101308 in cervical cancer and the prediction of its mechanism. Cancer Manag Res 12:4807\u20134815. https:\/\/doi.org\/10.2147\/CMAR.S242615","journal-title":"Cancer Manag Res"},{"key":"4395_CR9","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1186\/s13046-019-1437-z","volume":"38","author":"ZH Zong","year":"2019","unstructured":"Zong ZH, Du YP, Guan X, Chen S, Zhao Y (2019) CircWHSC1 promotes ovarian cancer progression by regulating MUC1 and hTERT through sponging miR-145 and miR-1182. J Exp Clin Cancer Res 38:437. https:\/\/doi.org\/10.1186\/s13046-019-1437-z","journal-title":"J Exp Clin Cancer Res"},{"key":"4395_CR10","doi-asserted-by":"publisher","first-page":"6898","DOI":"10.1111\/jcmm.15346","volume":"24","author":"Y Liu","year":"2020","unstructured":"Liu Y, Chen S, Zong ZH, Guan X, Zhao Y (2020) CircRNA WHSC1 targets the miR-646\/NPM1 pathway to promote the development of endometrial cancer. J Cell Mol Med 24:6898\u20136907. https:\/\/doi.org\/10.1111\/jcmm.15346","journal-title":"J Cell Mol Med"},{"key":"4395_CR11","doi-asserted-by":"publisher","first-page":"104704","DOI":"10.1016\/j.yexmp.2021.104704","volume":"123","author":"L Ding","year":"2021","unstructured":"Ding L, Xie Z (2021) CircWHSC1 regulates malignancy and glycolysis by the miR-212-5p\/AKT3 pathway in triple-negative breast cancer. Exp Mol Pathol 123:104704. https:\/\/doi.org\/10.1016\/j.yexmp.2021.104704","journal-title":"Exp Mol Pathol"},{"key":"4395_CR12","doi-asserted-by":"publisher","first-page":"653051","DOI":"10.3389\/fgene.2021.653051","volume":"12","author":"J Liu","year":"2021","unstructured":"Liu J, Zhu H, Fu L, Xu T (2021) Investigating the underlying mechanisms of circular RNAs and their application in clinical research of cervical cancer. Front Genet 12:653051. https:\/\/doi.org\/10.3389\/fgene.2021.653051","journal-title":"Front Genet"},{"key":"4395_CR13","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.omto.2020.03.024","volume":"17","author":"Q Wa","year":"2020","unstructured":"Wa Q, Zou C, Lin Z, Huang S, Peng X, Yang C, Ren D, Xu D, Guo Y, Liao Z, Wang B, Hu H, Huang S, He P (2020) Ectopic expression of miR-532-3p suppresses bone metastasis of prostate cancer cells via inactivating NF-kappaB signaling. Mol Ther Oncolytics 17:267\u2013277. https:\/\/doi.org\/10.1016\/j.omto.2020.03.024","journal-title":"Mol Ther Oncolytics"},{"key":"4395_CR14","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1080\/15384101.2021.1953767","volume":"20","author":"B Gao","year":"2021","unstructured":"Gao B, Wang L, Zhang Y, Zhang N, Han M, Liu H, Sun D, Liu Y (2021) MiR-532-3p suppresses cell viability, migration and invasion of clear cell renal cell carcinoma through targeting TROAP. Cell Cycle 20:1578\u20131588. https:\/\/doi.org\/10.1080\/15384101.2021.1953767","journal-title":"Cell Cycle"},{"key":"4395_CR15","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.3892\/etm.2021.10662","volume":"22","author":"H Chen","year":"2021","unstructured":"Chen H, Liu Y, Liu P, Dai Q, Wang P (2021) LINC01094 promotes the invasion of ovarian cancer cells and regulates the Wnt\/beta-catenin signaling pathway by targeting miR-532-3p. Exp Ther Med 22:1228. https:\/\/doi.org\/10.3892\/etm.2021.10662","journal-title":"Exp Ther Med"},{"key":"4395_CR16","doi-asserted-by":"publisher","first-page":"32469","DOI":"10.1016\/S0021-9258(18)31659-4","volume":"269","author":"A Moren","year":"1994","unstructured":"Moren A, Olofsson A, Stenman G, Sahlin P, Kanzaki T, Claesson-Welsh L, ten Dijke P, Miyazono K, Heldin CH (1994) Identification and characterization of LTBP-2, a novel latent transforming growth factor-beta-binding protein. J Biol Chem 269:32469\u201332478","journal-title":"J Biol Chem"},{"key":"4395_CR17","first-page":"1095","volume":"7","author":"Y Ren","year":"2015","unstructured":"Ren Y, Lu H, Zhao D, Ou Y, Yu K, Gu J, Wang L, Jiang S, Chen M, Wang J, Zhang R, Xu C (2015) LTPB2 acts as a prognostic factor and promotes progression of cervical adenocarcinoma. Am J Transl Res 7:1095\u20131105","journal-title":"Am J Transl Res"},{"key":"4395_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12061472","author":"P Dong","year":"2020","unstructured":"Dong P, Xu D, Xiong Y, Yue J, Ihira K, Konno Y, Watari H (2020) The expression, functions and mechanisms of circular RNAs in gynecological cancers. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers12061472","journal-title":"Cancers (Basel)"},{"key":"4395_CR19","doi-asserted-by":"publisher","first-page":"e13487","DOI":"10.1111\/eci.13487","volume":"51","author":"P Lyu","year":"2021","unstructured":"Lyu P, Zhai Z, Hao Z, Zhang H, He J (2021) CircWHSC1 serves as an oncogene to promote hepatocellular carcinoma progression. Eur J Clin Invest 51:e13487","journal-title":"Eur J Clin Invest"},{"key":"4395_CR20","doi-asserted-by":"publisher","first-page":"e23865","DOI":"10.1002\/jcla.23865","volume":"35","author":"F Shi","year":"2021","unstructured":"Shi F, Yang Q, Shen D, Chen J (2021) CircRNA WHSC1 promotes non-small cell lung cancer progression via sponging microRNA-296-3p and up-regulating expression of AKT serine\/threonine kinase 3. J Clin Lab Anal 35:e23865. https:\/\/doi.org\/10.1002\/jcla.23865","journal-title":"J Clin Lab Anal"},{"key":"4395_CR21","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/s41576-019-0158-7","volume":"20","author":"LS Kristensen","year":"2019","unstructured":"Kristensen LS, Andersen MS, Stagsted LVW, Ebbesen KK, Hansen TB, Kjems J (2019) The biogenesis, biology and characterization of circular RNAs. Nat Rev Genet 20:675\u2013691. https:\/\/doi.org\/10.1038\/s41576-019-0158-7","journal-title":"Nat Rev Genet"},{"key":"4395_CR22","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.omtn.2019.11.032","volume":"19","author":"F Ji","year":"2020","unstructured":"Ji F, Du R, Chen T, Zhang M, Zhu Y, Luo X, Ding Y (2020) Circular RNA circSLC26A4 accelerates cervical cancer progression via miR-1287-5p\/HOXA7 axis. Mol Ther Nucleic Acids 19:413\u2013420. https:\/\/doi.org\/10.1016\/j.omtn.2019.11.032","journal-title":"Mol Ther Nucleic Acids"},{"key":"4395_CR23","doi-asserted-by":"publisher","first-page":"3611","DOI":"10.2147\/CMAR.S238172","volume":"12","author":"R Chen","year":"2020","unstructured":"Chen R, Mao L, Shi R, Wang W, Cheng J (2020) circRNA MYLK accelerates cervical cancer via up-regulation of RHEB and activation of mTOR signaling. Cancer Manag Res 12:3611\u20133621. https:\/\/doi.org\/10.2147\/CMAR.S238172","journal-title":"Cancer Manag Res"},{"key":"4395_CR24","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1007\/s43032-020-00140-7","volume":"27","author":"J Li","year":"2020","unstructured":"Li J, Guo R, Liu Q, Sun J, Wang H (2020) Circular RNA Circ-ITCH inhibits the malignant behaviors of cervical cancer by microRNA-93-5p\/FOXK2 axis. Reprod Sci 27:860\u2013868. https:\/\/doi.org\/10.1007\/s43032-020-00140-7","journal-title":"Reprod Sci"},{"key":"4395_CR25","doi-asserted-by":"publisher","first-page":"485","DOI":"10.3389\/fgene.2020.00485","volume":"11","author":"M Liu","year":"2020","unstructured":"Liu M, Luo C, Dong J, Guo J, Luo Q, Ye C, Guo Z (2020) CircRNA_103809 suppresses the proliferation and metastasis of breast cancer cells by sponging MicroRNA-532-3p (miR-532-3p). Front Genet 11:485. https:\/\/doi.org\/10.3389\/fgene.2020.00485","journal-title":"Front Genet"},{"key":"4395_CR26","doi-asserted-by":"publisher","first-page":"7211","DOI":"10.26355\/eurrev_202007_21862","volume":"24","author":"K Huang","year":"2020","unstructured":"Huang K, Fan WS, Fu XY, Li YL, Meng YG (2020) Long noncoding RNA DARS-AS1 acts as an oncogene by targeting miR-532-3p in ovarian cancer. Eur Rev Med Pharmacol Sci 24:7211. https:\/\/doi.org\/10.26355\/eurrev_202007_21862","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"4395_CR27","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.matbio.2015.05.005","volume":"47","author":"IB Robertson","year":"2015","unstructured":"Robertson IB, Horiguchi M, Zilberberg L, Dabovic B, Hadjiolova K, Rifkin DB (2015) Latent TGF-beta-binding proteins. Matrix Biol 47:44\u201353. https:\/\/doi.org\/10.1016\/j.matbio.2015.05.005","journal-title":"Matrix Biol"},{"key":"4395_CR28","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.gene.2018.06.038","volume":"673","author":"F Suri","year":"2018","unstructured":"Suri F, Yazdani S, Elahi E (2018) LTBP2 knockdown and oxidative stress affect glaucoma features including TGFbeta pathways, ECM genes expression and apoptosis in trabecular meshwork cells. Gene 673:70\u201381. https:\/\/doi.org\/10.1016\/j.gene.2018.06.038","journal-title":"Gene"},{"key":"4395_CR29","doi-asserted-by":"publisher","first-page":"503","DOI":"10.3727\/096504016X14755368915591","volume":"25","author":"F Wan","year":"2017","unstructured":"Wan F, Peng L, Zhu C, Zhang X, Chen F, Liu T (2017) Knockdown of latent transforming growth factor-beta (TGF-beta)-binding protein 2 (LTBP2) inhibits invasion and tumorigenesis in thyroid carcinoma cells. Oncol Res 25:503\u2013510. https:\/\/doi.org\/10.3727\/096504016X14755368915591","journal-title":"Oncol Res"},{"key":"4395_CR30","doi-asserted-by":"publisher","first-page":"1886","DOI":"10.3892\/ijo.2018.4356","volume":"52","author":"J Wang","year":"2018","unstructured":"Wang J, Liang WJ, Min GT, Wang HP, Chen W, Yao N (2018) LTBP2 promotes the migration and invasion of gastric cancer cells and predicts poor outcome of patients with gastric cancer. Int J Oncol 52:1886\u20131898. https:\/\/doi.org\/10.3892\/ijo.2018.4356","journal-title":"Int J Oncol"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-022-04395-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11010-022-04395-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-022-04395-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,4]],"date-time":"2022-05-04T09:14:15Z","timestamp":1651655655000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11010-022-04395-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,2]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["4395"],"URL":"https:\/\/doi.org\/10.1007\/s11010-022-04395-3","relation":{},"ISSN":["0300-8177","1573-4919"],"issn-type":[{"value":"0300-8177","type":"print"},{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,2]]},"assertion":[{"value":"8 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The experiments were approved by the Ethics Committee of Shengjing Hospital of China Medical University.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not Applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}